Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sureyya Yigit Kaya"'
Autor:
Volkan Karakuş, Omur Gokmen Sevindik, Aylin Karatas, Emel Merve Yenihayat, Merve Gokcen Polat, Serhat Çelik, Ibrahim Ethem Pinar, Ali Dogan, Idris İnce, Umit Yavuz Malkan, Utku Iltar, Demircan Özdalcı Ozdalcı, Özgür Mehtap, Ramazan Erdem, Murat Kacmaz, Fatma Aykas, Berna Ozturk, Burak Deveci, Aydan Akdeniz, Hale Bulbul, Sureyya Yigit Kaya, Ferda Can, Zeynep Guven, Ceyda Aslan, Muzaffer Keklik, Fahir Ozkalemkas, Hakan Goker, İnci Alacacıoğlu
Introduction: To investigate the demographics and treatment details of the acute myeloid leukemia (AML) patients who were diagnosed and followed up in Turkey. Methods: Patients who were recorded on the database of Turkish AML Registry project were in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d669e7e8d417ece6ac4980d03e59a42
https://hdl.handle.net/20.500.12511/10631
https://hdl.handle.net/20.500.12511/10631
Autor:
Yasa Gul Mutlu, Sureyya Yıgıt Kaya, Senem Maral, Elif Melek, Zafer Baslar, Leylagul Kaynar, Omur Gokmen Sevindik
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Central nervous system (CNS) involvement in multiple myeloma (MM) is a rare and challenging complication associated with poor prognosis and limited treatment options. Emerging T-cell directing therapies, such as bispecific antibodies (bsAbs) and chim
Externí odkaz:
https://doaj.org/article/5bf26ad33bf34ce0b6a0aa517e9d10bb
Publikováno v:
Leukemia Research Reports, Vol 19, Iss , Pp 100369- (2023)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective option for the treatment of intermediate and high-risk Acute myeloid leukemia (AML). Post-transplant lymphoproliferative disorder (PTLD) is related to the intensity o
Externí odkaz:
https://doaj.org/article/d5c7e38b232b473a8a0d08052ce48a91
Autor:
Tulay, Kadioglu, Mehmet, Uzunlulu, Sureyya, Yigit Kaya, Aytekin, Oguz, Gokhan, Ggonenli, Banu, Isbilen, Ferruh, Isman
Publikováno v:
Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 68(5)
Kidney injury molecule-1 (KIM-1) is a type 1 tubular cell transmembrane protein that is found in high levels in early stages of acute kidney injury and is stated to have predictive value in the early diagnosis of chronic kidney diseases. In this stud